Given Imaging has reported three new studies that demonstrate the clinical utility of PillCam SB capsule endoscopy in providing physicians with critical information on how they manage and/or diagnose intestinal disorders. These studies were carried out in pediatric patients with gastrointestinal symptoms, including children with known or suspected Crohn’s disease.

The company said that the three studies were presented at the Gastro 2009 conference taking place in London, from November 21 to 25.

Ernest Seidman, professor of medicine and chair of IBD at McGill University Health Center, Canada, concluded that capsule endoscopy is clinically useful in symptomatic pediatric patients with known Crohn’s disease when endoscopic and barium studies are negative. As a result of the CE findings, study investigators changed how they clinically managed more than half of the patients in the study.

Fritscher-Ravens, professor of department of interdisciplinary endoscopy at University Hospital Kiel, Germany, said: “Capsule endoscopy is a powerful, non-invasive imaging modality that can impact pediatric patient outcomes. If no cause for symptoms can be determined, capsule endoscopy should always be considered, as both positive and negative findings from CE exams have led us to change how we manage pediatric patients, which often improves their quality of life.”

Homi Shamir, president and CEO of Given Imaging, said: “Children remain an important patient group for whom accurate diagnosis and treatment can significantly impact their lives, and we are pleased that these studies validate PillCam’s broader role in their diagnosis and management.”